web-based near real-time covid-19 dashboard (Johns Hopkins HealthCare)
90
Structured Review
Johns Hopkins HealthCare
web-based near real-time covid-19 dashboard
Web Based Near Real Time Covid 19 Dashboard, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/web-based+dashboard/covid+19+confirmed+cases/pmc11577003-164-11-16
Average 90 stars, based on 1 article reviews
Web Based Near Real Time Covid 19 Dashboard, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/web-based+dashboard/covid+19+confirmed+cases/pmc11577003-164-11-16
Average 90 stars, based on 1 article reviews
web-based near real-time covid-19 dashboard - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: An interactive national digital surveillance system to fight against COVID-19 in Bangladesh Article Snippet: The Center for Article Title: Warriors, Worriers, and COVID-19: An Exploratory Study of the Catechol O-Methyltransferase Val158Met Polymorphism Across Populations Article Snippet: Information on the total number of cases, recovered cases, and deaths for each nation was obtained on June 23, 2020, from the Article Title: Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines. Article Snippet: The top 10 countries according to ranks from the Article Title: Coronavirus and the race to distribute reliable diagnostics. Article Snippet: NaTuRe BIOTeChNOlOGy | VOL 38 | APRIL 2020 | 379–391 | www.nature.com/naturebiotechnology First CRISPR therapy dosed An adult with congenital blindness is the first person to receive an in vivo CRISPR-based therapy, according to the sponsors of the clinical trial: Editas Medicine and Allergan.. The trial is testing whether EDIT-101 (also known as AGN-151587) can remove a point mutation in the CEP290 gene, which causes type 10 of the retinal degenerative disease Leber congenital amaurosis (LCA).. The IVS26 mutation leads to a functional loss in the CEP290 protein, which causes defects in retinal photoreceptors and severe vision loss. |